Summary by Moomoo AI
Tongyuan Kang Pharmaceutical announced that a Board of Directors meeting will be held on Thursday, March 27, 2025, with the main agenda including the review and approval of the 2024 annual performance report and its publication, as well as considering the distribution of the final dividend. The company's Board of Directors is currently led by Dr. Wu Yusheng, Chairman and President, and consists of 2 executive directors, 5 non-executive directors, and 4 independent non-executive directors.
Comment(0)
Reason For Report